The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,084.00
Bid: 12,082.00
Ask: 12,086.00
Change: -72.00 (-0.59%)
Spread: 4.00 (0.033%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain

Mon, 11th Nov 2019 08:43

(Alliance News) - London stocks started the week on the back foot amid some rising unease over the US-China trade situation following a week of mixed headlines, with the FTSE 250 lower despite Sirius Minerals, Greggs and Aston Martin all racking up share price gains.

The FTSE 100 was 39.32 points lower, or 0.5%, at 7,320.06 early Monday. The FTSE 250 was down 65.24 points, or 0.3%, at 20,292.39, and the AIM All-Share was down 0.1% at 890.78.

The Cboe UK 100 index was up down 0.6% at 12,406.34. The Cboe UK 250 was down 0.1% at 18,233.01 and the Cboe UK Small Companies was flat at 11,258.26.

In European equities, the CAC 40 index in Paris was down 0.1% and the DAX 30 in Frankfurt down 0.3% in early trade.

In Asia on Monday, the Japanese Nikkei 225 index closed down 0.3%. In China, the Shanghai Composite ended down 1.8%, while the Hang Seng index in Hong Kong finished 2.6% lower.

"Civil unrest in Hong Kong and mixed signals on the progress of US/China trade talks has dampened sentiment across financial markets. Most Asian equity markets have started the week lower as a result, with Hong Kong stocks leading the decline following violent clashes this morning," said Lloyds Banking.

Though there were broad-based losses in the FTSE 100, AstraZeneca was sat atop the index, up 0.9% after reporting positive results for an anaemia drug.

Astra said analyses of a Roxadustat drug trial for the treatment of patients with anaemia from chronic kidney disease showed positive efficacy and no increased risk of major adverse cardiovascular events.

The FTSE 250 was lower despite some solid share price gains from the likes of Sirius Minerals, Greggs and Aston Martin.

Sirius Minerals shares surged 14% after outlining a new two-stage development plan for its North Yorkshire polyhalite mine as it looks to secure funding for the first stage of the project.

In September, Sirius announced it struggled to secure the required funding for its current project plan due to "market conditions." Consequently, the firm intended to slow the development of its polyhalite mine.

Sirius remains focused on extracting first polyhalite from the mine in order to remove the "greatest perceived construction risk associated with deep shaft construction." This will allow Sirius to explore a wider and cheaper range of long-term financing options for the ramping-up of production.

The Scarborough-based firm expects the initial phase to require around USD600 million in investment in addition to its current cash reserves.

Baker Greggs was up 6.9% after upgrading its guidance again.

In the period to November 9, total sales were up 12% year-on-year and the bakery chain registered like-for-like growth of 8.3% in its company-managed shops. In the same period last year, total sales rose by 8.3% and by 4.0% on a like-for-like basis.

The FTSE 250 firm now expects its full-year pretax profit, excluding exceptional costs, to be higher than previous internal expectations.

Greggs explained: "Sales growth continues to be driven by increased customer visits and has been stronger than we had expected given the improving comparative sales pattern that we saw in the fourth quarter last year. Operational costs remain well controlled and, whilst the comparative sales become stronger still in the balance of the year."

The company previously hiked its 2019 pretax profit guidance in February, after reporting a sales surge helped by its vegan sausage rolls.

Aston Martin shares rose 5.0% after HSBC raised the stock to Buy from Hold.

In Monday's economic calendar, there are UK GDP, manufacturing production, industrial production and trade balance reports at 0930 GMT.

"Given the weak PMIs, growth seems to remain sluggish but there might have been a positive contribution from stockpiling ahead of the previous 31 October Brexit deadline," commented Danske Bank.

Consensus, according to FXStreet, is for UK GDP in the third quarter of grow 0.3% quarter-on-quarter, after a 0.2% contraction in the preceding three months. Any reading which indicates the UK economy shrank in the three months to September will put the country into a technical recession.

The data comes after Moody's Investors Service on Friday downgraded the outlook for Britain's debt, citing mounting policy challenges amid the Brexit debate.

The agency cut the outlook to negative from stable but kept the debt at the investment-grade Aa2. Ratings agency Fitch had similarly put Britain on "negative watch" in February.

Pointing to "paralysis that has characterised the Brexit-era policymaking process," Moody's said London has "struggled to cope with the magnitude of policy challenges that they currently face."

The pound was quoted at USD1.2799 early Monday, up from USD1.2784 late Friday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.